Esterase-activated chromane-sydnonimine prodrug hybrids

Nitric Oxide. 2006 Dec;15(4):363-9. doi: 10.1016/j.niox.2006.03.006. Epub 2006 Apr 27.

Abstract

The preparation and characterization of two vitamin E analogs-sydnonimine conjugates, delta-tocopheryloxycarbonyl-3-morpholinosydnonimine (2) and troloxoxycarbonyl-3-morpholinosydnonimine (3), in which the hydroxyl group of the tocopheryl moieties is linked via an enzymatically cleavable urethane group to the sydnone moiety is described. In the presence of porcine liver esterase, these tocopheryl-sydnonimine conjugates generated the expected antioxidant moieties, i.e., delta-tocopherol or Trolox, and were found to convert oxyhemoglobin to methemoglobin at 37 degrees C in 50 mM phosphate buffer at pH 7.4, thus providing evidence for nitric oxide release. Their potency as antioxidants was indirectly studied by associating the two products of the hydrolysis, SIN-1, and delta-tocopherol or Trolox. Our findings suggest that unlike the other members of the sydnonimine family these chromane-sydnonimine derivatives do not act as peroxynitrite donors, and require enzymatic bioactivation before nitric oxide or nitroxyl anion (NO(-)) can be released.

MeSH terms

  • Chromans / metabolism
  • Chromans / pharmacology*
  • Esterases / metabolism*
  • Hydrogen-Ion Concentration
  • Magnetic Resonance Spectroscopy
  • Morpholines / metabolism
  • Morpholines / pharmacology*
  • Nitric Oxide Donors / metabolism
  • Nitric Oxide Donors / pharmacology*
  • Prodrugs / metabolism
  • Prodrugs / pharmacology*
  • Spectrophotometry, Ultraviolet
  • Sydnones / metabolism
  • Sydnones / pharmacology*

Substances

  • Chromans
  • Morpholines
  • Nitric Oxide Donors
  • Prodrugs
  • Sydnones
  • Esterases